Biomerica Secures Three Key International Patents for inFoods T
| BMRA Stock | USD 0.32 0.02 5.88% |
About 55% of Biomerica's investors are presently thinking to get in. The analysis of overall sentiment of trading Biomerica stock suggests that some investors are interested at this time. The current market sentiment, together with Biomerica's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomerica stock news signals to limit their universe of possible portfolio assets.
Biomerica |
New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD , Crohns Disease , and Ulcerative
Read at gurufocus.com
 |
Biomerica Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Biomerica can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biomerica Fundamental Analysis
We analyze Biomerica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomerica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomerica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Biomerica is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Biomerica Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomerica stock to make a market-neutral strategy. Peer analysis of Biomerica could also be used in its relative valuation, which is a method of valuing Biomerica by comparing valuation metrics with similar companies.
Peers
Biomerica Related Equities
| MOVE | Movano | 5.65 | ||||
| TNON | Tenon Medical | 3.95 | ||||
| NXL | Nexalin Technology | 2.63 | ||||
| AIMD | Ainos | 2.33 | ||||
| SGHT | Sight Sciences | 0.80 | ||||
| SSKN | STRATA Skin | 0.32 | ||||
| SRDX | SurModics | 0.05 | ||||
| NPCE | Neuropace | 2.07 | ||||
| BBLG | Bone Biologics | 2.38 | ||||
| TIVC | Tivic Health | 4.00 | ||||
| MODD | Modular Medical | 5.83 |
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |